Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Crawford Healthcare Ltd, Kind Edward Court, Kind Edward Road, Knutsford, Cheshire, WA16 0BE, United Kingdom
Zindaclin 1% Gel.
| Pharmaceutical Form |
|---|
|
Gel. A white translucent gel. |
1g of gel contains 10mg clindamycin (1% w/w) equivalent to 11.88 mg clindamycin phosphate. Zindaclin 1% Gel also contains 40% w/w propylene glycol.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clindamycin |
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
| List of Excipients |
|---|
|
Propylene glycol |
Zindaclin is packaged in 15g, 30g, 60g laminate tubes with a high-density polyethylene inner layer and a peelable membrane laminate seal covering the orifice. The tube is fitted with a white opaque polypropylene screw cap.
Not all pack sizes may be marketed.
Crawford Healthcare Ltd, Kind Edward Court, Kind Edward Road, Knutsford, Cheshire, WA16 0BE, United Kingdom
PA 1098/001/001
Date of first authorisation: 22 November 2002
Date of last renewal: 16 August 2006
| Drug | Countries | |
|---|---|---|
| ZINDACLIN | Austria, Spain, Hong Kong, Ireland, Israel, Singapore, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
